DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,258 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $141,416 | +6.8% | 566 | +6.8% | 0.02% | +6.7% |
| Q1 2024 | $132,352 | +17.2% | 530 | +8.6% | 0.02% | +7.1% |
| Q4 2023 | $112,894 | -9.5% | 488 | -3.0% | 0.01% | -17.6% |
| Q3 2023 | $124,795 | +22.9% | 503 | +18.9% | 0.02% | +30.8% |
| Q2 2023 | $101,520 | -7.6% | 423 | -3.0% | 0.01% | -13.3% |
| Q1 2023 | $109,890 | -10.6% | 436 | -5.8% | 0.02% | -21.1% |
| Q4 2022 | $122,889 | -27.3% | 463 | -29.1% | 0.02% | -34.5% |
| Q3 2022 | $169,000 | +111.2% | 653 | +107.3% | 0.03% | +107.1% |
| Q2 2022 | $80,000 | -1.2% | 315 | +14.1% | 0.01% | +16.7% |
| Q1 2022 | $81,000 | -10.0% | 276 | +0.7% | 0.01% | -7.7% |
| Q4 2021 | $90,000 | +16.9% | 274 | +8.3% | 0.01% | 0.0% |
| Q3 2021 | $77,000 | +54.0% | 253 | +34.6% | 0.01% | +62.5% |
| Q2 2021 | $50,000 | +108.3% | 188 | +79.0% | 0.01% | +100.0% |
| Q1 2021 | $24,000 | +20.0% | 105 | +16.7% | 0.00% | 0.0% |
| Q4 2020 | $20,000 | +5.3% | 90 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | +18.8% | 90 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $16,000 | +33.3% | 90 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $12,000 | -14.3% | 90 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $14,000 | +7.7% | 90 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $13,000 | 0.0% | 90 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $13,000 | +8.3% | 90 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $12,000 | +9.1% | 90 | -18.2% | 0.00% | 0.0% |
| Q4 2018 | $11,000 | -8.3% | 110 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $12,000 | +9.1% | 110 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,000 | +10.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $10,000 | +11.1% | 110 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $9,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $9,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $9,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $9,000 | 0.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $9,000 | -18.2% | 110 | 0.0% | 0.00% | -25.0% |
| Q2 2016 | $11,000 | +10.0% | 110 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $10,000 | -47.4% | 110 | -45.0% | 0.00% | -42.9% |
| Q4 2015 | $19,000 | +11.8% | 200 | 0.0% | 0.01% | -12.5% |
| Q3 2015 | $17,000 | 0.0% | 200 | 0.0% | 0.01% | +14.3% |
| Q2 2015 | $17,000 | 0.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $17,000 | +466.7% | 200 | +440.5% | 0.01% | +600.0% |
| Q4 2014 | $3,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |